Market Cap 190.00M
Revenue (ttm) 4.35M
Net Income (ttm) -45.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,046.67%
Debt to Equity Ratio 0.86
Volume 748,800
Avg Vol 1,471,530
Day's Range N/A - N/A
Shares Out 137.68M
Stochastic %K 13%
Beta 1.18
Analysts Strong Sell
Price Target $3.95

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths th...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
irishguy007
irishguy007 Mar. 20 at 7:26 PM
$LUCD Thank god it’s the weekend!! So done with this week.
1 · Reply
JRINPHX
JRINPHX Mar. 20 at 7:10 PM
$LUCD meanwhile, back at the ranch… The share price keeps coming down. If it gets back to $1.00 I “might” buy back in. … Maybe.
0 · Reply
xx007xx
xx007xx Mar. 20 at 2:00 PM
$LUCD so glad I’m being “tolerated”. Again, feel bad for you. 🥺Bless your heart.
0 · Reply
xx007xx
xx007xx Mar. 20 at 11:38 AM
$LUCD the resident 🧌 that has multiple personalities/identities seems to think deflecting is the best way to approach the fact that it’s been here for years trashing this stock. This individual was FIRED and no longer a part of their organization. Yet continues to hang around because they’re a scorned ex-lover who can’t get over their narcissistic tendencies and belief that THEY are NOT the smartest person in the room. There’s a reason THEY are not there anymore. I don’t need multiple handles to try and “trick” others into thinking that multiple people are having a conversation and trashing a stock. There is ONE of you, yet unfortunately you’re under the delusion that there are MULTIPLE of “you”. I trade & invest where I see value. NEVER do I waste my time bashing a stock, day in and day out. I’ve made great trades, I’ve made poor trades recently. However, I OWN shares here where YOU, SIR, do NOT. It’s time to move along and find something new to do with your time. Its sad.
2 · Reply
dmc4321
dmc4321 Mar. 20 at 8:58 AM
$LUCD & $PAVM @Tom__Brady Are you Walter Mitty? If we were to look at your timeline would we see you PUMPING and EXTOLLING the virtues of winners or LOSERS? What do you think? Everybody knows who I am. It is not a secret. You however are modelling yourself after a fictional character. So people can make of that what they may.
1 · Reply
oaksapollo
oaksapollo Mar. 19 at 6:17 PM
$LUCD hmmm...if only there were a super simple, readily available way to improve outcomes
1 · Reply
xx007xx
xx007xx Mar. 19 at 5:01 PM
$LUCD $PAVM absolute 🤡 if you only knew…
0 · Reply
ConditionalInvesting
ConditionalInvesting Mar. 19 at 2:05 PM
$LUCD unfortunately, the uptrend has been broken! I see this heading down below 1.20. Let's get the LCD! Move your butt MolDx!
1 · Reply
BigJuicy
BigJuicy Mar. 19 at 1:28 PM
$LUCD taking side bets on the price once LCD comes out. My guess is 2.50$. $PAVM 25$…. Who will be closest?
1 · Reply
Ironbow
Ironbow Mar. 19 at 1:16 PM
$LUCD $PAVM Dave switched accounts; dmc4321 and LaPlates are just spreading FUD; Fear uncertainty and doubt… classic tactic…. Ignore 👇🏻
2 · Reply
Latest News on LUCD
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 2:41 PM EST - 4 months ago

Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript


Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 4:39 PM EDT - 7 months ago

Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript


Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript

Mar 24, 2025, 12:17 PM EDT - 1 year ago

Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript


irishguy007
irishguy007 Mar. 20 at 7:26 PM
$LUCD Thank god it’s the weekend!! So done with this week.
1 · Reply
JRINPHX
JRINPHX Mar. 20 at 7:10 PM
$LUCD meanwhile, back at the ranch… The share price keeps coming down. If it gets back to $1.00 I “might” buy back in. … Maybe.
0 · Reply
xx007xx
xx007xx Mar. 20 at 2:00 PM
$LUCD so glad I’m being “tolerated”. Again, feel bad for you. 🥺Bless your heart.
0 · Reply
xx007xx
xx007xx Mar. 20 at 11:38 AM
$LUCD the resident 🧌 that has multiple personalities/identities seems to think deflecting is the best way to approach the fact that it’s been here for years trashing this stock. This individual was FIRED and no longer a part of their organization. Yet continues to hang around because they’re a scorned ex-lover who can’t get over their narcissistic tendencies and belief that THEY are NOT the smartest person in the room. There’s a reason THEY are not there anymore. I don’t need multiple handles to try and “trick” others into thinking that multiple people are having a conversation and trashing a stock. There is ONE of you, yet unfortunately you’re under the delusion that there are MULTIPLE of “you”. I trade & invest where I see value. NEVER do I waste my time bashing a stock, day in and day out. I’ve made great trades, I’ve made poor trades recently. However, I OWN shares here where YOU, SIR, do NOT. It’s time to move along and find something new to do with your time. Its sad.
2 · Reply
dmc4321
dmc4321 Mar. 20 at 8:58 AM
$LUCD & $PAVM @Tom__Brady Are you Walter Mitty? If we were to look at your timeline would we see you PUMPING and EXTOLLING the virtues of winners or LOSERS? What do you think? Everybody knows who I am. It is not a secret. You however are modelling yourself after a fictional character. So people can make of that what they may.
1 · Reply
oaksapollo
oaksapollo Mar. 19 at 6:17 PM
$LUCD hmmm...if only there were a super simple, readily available way to improve outcomes
1 · Reply
xx007xx
xx007xx Mar. 19 at 5:01 PM
$LUCD $PAVM absolute 🤡 if you only knew…
0 · Reply
ConditionalInvesting
ConditionalInvesting Mar. 19 at 2:05 PM
$LUCD unfortunately, the uptrend has been broken! I see this heading down below 1.20. Let's get the LCD! Move your butt MolDx!
1 · Reply
BigJuicy
BigJuicy Mar. 19 at 1:28 PM
$LUCD taking side bets on the price once LCD comes out. My guess is 2.50$. $PAVM 25$…. Who will be closest?
1 · Reply
Ironbow
Ironbow Mar. 19 at 1:16 PM
$LUCD $PAVM Dave switched accounts; dmc4321 and LaPlates are just spreading FUD; Fear uncertainty and doubt… classic tactic…. Ignore 👇🏻
2 · Reply
LPlates
LPlates Mar. 19 at 1:12 PM
$LUCD $PAVM Please explain why at the CAC meeting for EsoGuard all the participants used the BEST3 trial from Cyted Health as proof of "Real World Evidence" that a non invasive sampling device can be a valuable triage tool. Just search the transcript for BEST3. During the meeting, the panelists frequently used Cyted Health's BEST3 trial (the landmark randomized controlled trial for the Cytosponge-TFF3) as the primary benchmark for "clinical utility." So while you ATTEMPT to rubbish Cyted Healths diagnostics test it has been out longer and done more paid tests. That's just a FACT. So unless you consider yourself more of an expert than the specialists on the CAC call. (Did you turn down your invitation to speak 🤔?) Maybe you should accept you are DUMBER than a rock and stay quiet.
1 · Reply
ShaolinViolin23
ShaolinViolin23 Mar. 19 at 12:33 PM
$LUCD welps slow bleed back to the 1.10s
0 · Reply
trout290zzaam
trout290zzaam Mar. 19 at 12:27 PM
$LUCD Imo, our inflection point is the point that we become derisked. For me, that point is not necessarily LCD, but I am curious to hear if others have any logical opinions.
3 · Reply
xx007xx
xx007xx Mar. 19 at 12:13 PM
$LUCD $PAVM Cyted is ANOTHER SPONGE on a STRING. Medtronic showed that clinical viability is trash. Why on earth do you continue to peddle this trash on here? You should know better than that, yet here you are, as always. CYTED IS NOT THE SAME. CYTED IS a CYTOSPONGE EQUIVALENT. Your credibility with this is ZERO and viewed as the resident troll and that’s all. It doesn’t take a genius to see this so not sure why you spend day in and day out bashing it. Obviously you’re a scorned ex lover of their organization and want to try and pull it through the mud constantly. Pathetic. Truly sad.
1 · Reply
BigJuicy
BigJuicy Mar. 19 at 12:03 PM
$LUCD looks like the LCD is coming sometime in May / June. Not sure why everyone is expecting this in March at 6 months. These usually happen closer to 9 months from CAC from my research.
1 · Reply
dmc4321
dmc4321 Mar. 19 at 6:25 AM
$LUCD & $PAVM This is just wrong. EsoCheck has got FDA approval and EsoGuard got a FDA Breakthrough Device Designation which has nothing to do with the 510 pathway. Cyted Health also has FDA approval since February 2024, and raised $44M in August 2025 to launch in the USA. It was Cyted Healths data from their UK clinical trial that was used as the basis for discussion at EsoGuards CAC meeting in September 2025 for "real world evidence" as EsoGuard did not have that evidence. There is also Previse which is now owned by Castle Biosciences which has a clear focus on esophageal cancers and has a large sales and marketing force already calling on the GI's etc as they SUCESSFULLY sell TissueCypher. So there is well funded EXISTING SUCESSFUL competitors in this niche. After approval you need to sell EsoGuard and the only concrete data we have is LUCD's 29 salespeople only managed to sell less than 2 covered tests a week in 1H 2025. That does not scale. AT ALL. MASSIVE DILUTION INCOMING1
1 · Reply
RetiredMD
RetiredMD Mar. 19 at 6:08 AM
$LUCD 🤦🏻‍♂️
0 · Reply
oaksapollo
oaksapollo Mar. 19 at 6:06 AM
0 · Reply
BlameTheBartender
BlameTheBartender Mar. 18 at 7:46 PM
$LUCD There is a huge market for Esoguard. It is the only preventative test approved by the FDA-plus it is 99% accurate. 16k deaths per year in us alone-500k new cases of esophgeal cancer every year. Every single occupation that involves breathing potential carcinogens is a potential client.
2 · Reply
Ironbow
Ironbow Mar. 18 at 5:54 PM
$LUCD $PAVM Dmc4321 aka Dave, just woke up from his patty’s day banger !! Ignore
1 · Reply
dmc4321
dmc4321 Mar. 18 at 5:12 PM
$LUCD & $PAVM this response reconsiles my Grok analysis with your Grok analysis. YOU WILL NOT LIKE IT!!! Revised timeline: Draft LCD most likely July–September 2026 (Q3) at the earliest, or potentially later / no draft in 2026 if evidence gaps persist. Consolidated Best Estimate (as of March 18, 2026)Taking both of my prior responses into account — the initial process-flow estimate (optimistic April–May draft tied to the June 9 open meeting) and the subsequent red-team critique (deeper dive into the actual CGS page language, housekeeping revisions, active LCD text, MolDX guidance, and peer-review realities) — here is the reconciled view: Revised timeline: Draft LCD most likely July–September 2026 (Q3) at the earliest, or potentially later / no draft in 2026 if evidence gaps persist. This is a meaningful shift from the original “April or May” prediction, but still within the broader 3–9 month post-CAC window I originally cited. THE LINK SO YOU CAN SEE THE FULL CHAT https://x.com/i/grok/share/0cd15e7cf5ad43dc8c3184593a6c256
2 · Reply
profitprohpet
profitprohpet Mar. 18 at 4:59 PM
$LUCD Even if Esogaurd gets cleared for coverage, is there a significant market for this product? The demonstration still seems invasive and uncomfortable for the patient. From the physicians I have spoken with, they do not seem bullish on the product or did not know it exists. Anyone have some insight on this? Disclaimer: I am a shareholder
6 · Reply